[HTML][HTML] Structure-based drug design with geometric deep learning
Abstract Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
Structure-based drug design with geometric deep learning
C Isert, K Atz, G Schneider - Current opinion in structural …, 2023 - pubmed.ncbi.nlm.nih.gov
Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
Structure-based drug design with geometric deep learning
C Isert, K Atz, G Schneider - Current Opinion in …, 2023 - research-collection.ethz.ch
Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
Structure-based drug design with geometric deep learning.
C Isert, K Atz, G Schneider - Current Opinion in Structural Biology, 2023 - europepmc.org
Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
Structure-based drug design with geometric deep learning
C Isert, K Atz, G Schneider - arXiv preprint arXiv:2210.11250, 2022 - arxiv.org
Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
Structure-based drug design with geometric deep learning
C Isert, K Atz, G Schneider - arXiv e-prints, 2022 - ui.adsabs.harvard.edu
Abstract Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …